These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 7493602

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical studies on blood coagulation factors, prothrombin, factor V and factor VII liver diseases and their response to vitamin K1 and synka-vit].
    WITTE S, DIRNBERGER P.
    Klin Wochenschr; 1953 Sep 01; 31(33-34):781-7. PubMed ID: 13097910
    [No Abstract] [Full Text] [Related]

  • 23. Studies on the mode of action of vitamin K.
    Olson RE.
    Adv Enzyme Regul; 1966 Sep 01; 4():181-96. PubMed ID: 4168681
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
    Zivelin A, Rao LV, Rapaport SI.
    J Clin Invest; 1993 Nov 01; 92(5):2131-40. PubMed ID: 8227329
    [Abstract] [Full Text] [Related]

  • 29. Vitamin K-dependent coagulation factors and fibrinogen levels in FFP remain stable upon repeated freezing and thawing.
    Ben-Tal O, Zwang E, Eichel R, Badalbev T, Hareuveni M.
    Transfusion; 2003 Jul 01; 43(7):873-7. PubMed ID: 12823746
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Potency and coagulation factor effects of 2,3,5,6-tetrachloro-4-pyridinol compared to warfarin and its antagonism by vitamin K.
    Marshall FN.
    Proc Soc Exp Biol Med; 1972 Mar 01; 139(3):806-10. PubMed ID: 5023769
    [No Abstract] [Full Text] [Related]

  • 34. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
    O'Leary DS, Ruymann FB, Conrad ME.
    J Lab Clin Med; 1971 Jan 01; 77(1):23-32. PubMed ID: 5540427
    [No Abstract] [Full Text] [Related]

  • 35. Factor II, VII, IX and X concentrations in patients receiving long term warfarin.
    Paul B, Oxley A, Brigham K, Cox T, Hamilton PJ.
    J Clin Pathol; 1987 Jan 01; 40(1):94-8. PubMed ID: 3818977
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Warfarin therapy. 1.
    Deykin D.
    N Engl J Med; 1970 Sep 24; 283(13):691-4. PubMed ID: 4916914
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.